Back | Next |
home / stock / etnb / etnb message board
Subject | By | Source | When |
---|---|---|---|
Price trading | subslover | investorshub | 06/05/2023 2:03:46 AM |
$ETNB and the shorts continue | doogdilinger | investorshub | 06/04/2023 8:11:01 PM |
Anyone hear anything lately? Want to see this one go | subslover | investorshub | 06/04/2023 11:28:57 AM |
The gaining | subslover | investorshub | 05/30/2023 6:23:11 AM |
MomentumIts gaining last trade up | MiamiGent | investorshub | 05/29/2023 10:37:28 AM |
$ETNB When is this gonna take off? | subslover | investorshub | 05/25/2023 3:42:16 AM |
The now | doogdilinger | investorshub | 05/24/2023 4:32:12 PM |
$ETNB Thoughts on where this is headed? | doczaius | investorshub | 05/24/2023 4:56:24 AM |
$ETNB Looks pretty positive | doogdilinger | investorshub | 05/24/2023 3:20:33 AM |
lol, dat's me! | MiamiGent | investorshub | 03/24/2023 10:41:02 PM |
https://www.walmart.com/ip/Oh-The-Pain-Doctor-Smith-Lost-In-Space-Pinback-Button | subslover | investorshub | 03/24/2023 5:45:31 PM |
Oh the pain of only making a lot | MiamiGent | investorshub | 03/24/2023 3:30:45 PM |
$ETNB $18.03 another 52 week high | subslover | investorshub | 03/24/2023 1:38:05 PM |
$17.56 ---NEW 52-week high! | subslover | investorshub | 03/23/2023 8:19:16 PM |
We broke the 52-week high! :) | subslover | investorshub | 03/23/2023 3:34:40 PM |
$ETNB I only caught 70% of today's maximum | MiamiGent | investorshub | 03/23/2023 2:06:05 AM |
$ETNB: Here's a good one, too! (John Denver | Invest-in-America | investorshub | 03/22/2023 5:35:48 PM |
$ETNB: FUNNY!!!! Who knew????? | Invest-in-America | investorshub | 03/22/2023 5:31:21 PM |
Hey Miamigent. I can relate all the way. | subslover | investorshub | 03/22/2023 4:51:14 PM |
Oh here is a link for the Chairman | subslover | investorshub | 03/22/2023 4:46:21 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that data from the 48-week exten...
—With the initiation of ENLIGHTEN-Cirrhosis, pegozafermin is the first FGF21 analog to enter a Phase 3 trial in MASH patients with compensated cirrhosis (F4)— —Regression of fibrosis by histology at month 24 will serve as the basis for potential accelerated approval...